Biomarker extracellular matrix specialist
Total Trials
21
As Lead Sponsor
8
As Collaborator
13
Total Enrollment
27,442
NCT00486317
Pharmacokinetics/Pharmacodynamics of Oral Salmon Calcitonin in Patients With Osteoarthritis
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 31, 2005
Completion: Not specified
NCT00486369
SMC021A - Absorption, Efficacy and Tolerance in Patients With Osteoarthritis. A Placebo-Controlled 14-Days Study
Start: Jan 31, 2007
NCT00525798
A Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D
Phase: Phase 3
Start: Mar 31, 2007
Completion: Nov 30, 2011
NCT00486434
Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis
Start: May 31, 2007
Completion: Sep 30, 2010
NCT00704847
Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis (OA 2 Study)
Start: Jun 30, 2008
Completion: Jun 30, 2011
NCT01674621
Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis
Phase: Phase 2
Role: Collaborator
Start: Sep 25, 2012
Completion: Aug 2, 2013
NCT01919164
A Study to Investigate the Safety and Effectiveness of Different Doses of Sprifermin in Participants With Osteoarthritis of the Knee
Start: Jul 29, 2013
Completion: May 7, 2019
NCT02755441
Pulmonary Fibrosis Biomarker Cohort - a Prospective Cohort of Incident Patients With IPF
Phase: N/A
Start: Apr 30, 2016
Completion: Dec 31, 2028
NCT03231280
A Trial of a Single Delivery of SB-061 in Osteoarthritis of the Knee
Phase: Phase 1/2
Start: Aug 14, 2017
Completion: Mar 27, 2018
NCT03230786
Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes
Start: Aug 23, 2017
Completion: Jul 31, 2018
NCT03308916
Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers
Start: Oct 6, 2017
Completion: Oct 30, 2035
NCT03883568
A 2-year, European Multicentre Study to Describe, Validate, and Predict Phenotypes of Knee Osteoarthritis
Start: Jan 19, 2018
Completion: Dec 1, 2021
NCT03907202
A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM
Start: Apr 17, 2018
Completion: Dec 3, 2019
NCT04552106
Dose Finding Evaluation of Kudzu Root Extract in Women With Menopause Symptoms
Start: Aug 7, 2018
Completion: Nov 15, 2018
NCT04542655
The Effect of Exercise on Serum Levels of Collagen and Proteoglycan in Patients With Knee Osteoarthritis (EFEX-OA-01)
Start: Jan 7, 2019
Completion: May 14, 2019
NCT04333160
Phase III Study on the Safety and Efficacy of a Single Intra-articular Administration of JTA-004 in Symptomatic Knee Osteoarthritis
Start: Mar 10, 2020
Completion: Dec 9, 2021
NCT04498650
A Study to Evaluate Safety and Tolerability of Different Doses and Efficacy of PQ912 in Subjects With MCI and Mild AD
Start: Jul 6, 2020
Completion: Jan 12, 2024
NCT04542668
The Effect of Exercise on Serum Levels of Collagen and Proteoglycan in Patients With Knee Osteoarthritis
Start: Oct 8, 2020
Completion: Jun 7, 2021
NCT05414578
NORDTREAT Prospective Study on Inflammatory Bowel Disease
Start: Feb 7, 2022
Completion: Jan 31, 2031
NCT05651724
Global Research Initiative for Patients Screening on MASH
Start: Jun 30, 2023
Completion: Mar 31, 2031
NCT05312853
Evaluating the Diagnostic and Predictive Value of Non-invasive Tests (NITs) on the Progression of Chronic Liver Disease.
Start: Jan 15, 2024
Completion: Dec 31, 2034
Loading map...